Recent Security Class Actions

Taro Pharmaceutical Industries Ltd. Ordinary Shares (NYSE: TARO)

17 Days left to seek lead plaintiff status.

Company Name:Taro Pharmaceutical Industries Ltd. Ordinary Shares
Stock Symbol:NYSE: TARO
Class Period Start:01/17/2024
Class Period End (inclusive):09/09/2024
Filing Deadline:11/08/2024

On April 15, 2024, Defendants filed a proxy statement with the United States Securities and Exchange Commission in connection with the Proposed Transaction. The Complaint alleges that the Proxy Statement omitted material information with respect to the Proposed Transaction, rendering the Proxy Statement false and misleading. Specifically, the Complaint alleges the Proxy contained materially incomplete and misleading information concerning BofA Securities, Inc.’s methodology and key assumptions in describing the valuation analyses that BofA Securities performed.

Taro Pharmaceutical Industries Ltd. Ordinary Shares (NYSE: TARO) Claim Form

Name(Required)
Address
This field is for validation purposes and should be left unchanged.